| 1. |
Woodhead MA,Macfarlane JT,Rodgers FG,et al.Aetiology and outcome of severe community-acquired pneumonia.J Infect,1985,10(3):204-210.
|
| 2. |
Leeper KV Jr.Severe community-acquired pneumonia.Semin Respir Infect,1996,11(2):96-108.
|
| 3. |
Lozano R,Naghavi M,Foreman K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010.Lancet,2012,380(9859):2095-2128.
|
| 4. |
中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南.中华结核和呼吸杂志,2006,29(10):651-655.
|
| 5. |
Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis,2007,44(Suppl 2):S27-72.
|
| 6. |
Lim WS,Baudouin SV,George RC,et al.BTS guidelines for the management of community acquired pneumonia in adults:update 2009.Thorax,2009,64(Suppl 3):iii1-55.
|
| 7. |
Miyashita N,Matsushima T,Oka M,et al.The JRS guidelines for the management of community-acquired pneumonia in adults:an update and new recommendations.Intern Med,2006,45(7):419-428.
|
| 8. |
Spindler C,Stralin K,Eriksson L,et al.Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults-Swedish Society of Infectious Diseases 2012.Scand J Infect Dis,2012,44(12):885-902.
|
| 9. |
Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336(4):243-250.
|
| 10. |
Chalmers JD,Singanayagam A,Akram AR,et al.Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.J Antimicrob Chemother,2011,66(2):416-423.
|
| 11. |
Chen JH,Chang SS,Liu JJ,et al.Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults,elderly and very old subjects.Thorax,2010,65(11):971-977.
|
| 12. |
Lim WS,van der Eerden MM,Laing R,et al.Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study.Thorax,2003,58(5):377-382.
|
| 13. |
Serisier DJ,Williams S,Bowler SD.Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia.Respirology,2013,18(2):291-296.
|
| 14. |
Bauer TT,Ewig S,Marre R,et al.CRB-65 predicts death from community-acquired pneumonia.J Intern Med,2006,260(1):93-101.
|
| 15. |
Ewig S,Welte T.CRB-65 for the assessment of pneumonia severity:who could ask for more.Thorax,2008,63(8):665-666.
|
| 16. |
Charles PG.Predicting CAP-related mortality with CRB-65.Thorax,2011,66(3):262.
|
| 17. |
Loke YK,Kwok CS,Niruban A,et al.Value of severity scales in predicting mortality from community-acquired pneumonia:systematic review and meta-analysis.Thorax,2010,65(10):884-890.
|
| 18. |
Khawaja A,Zubairi AB,Durrani FK,et al.Etiology and outcome of severe community acquired pneumonia in immunocompetent adults.BMC Infect Dis,2013,13:94.
|
| 19. |
杨丹榕,张云娇,徐凌,等.以指南和肺炎严重程度指数为标准分层确立社区获得性肺炎患者住院指征的对照分析.中华结核和呼吸杂志,2008,31(8):628.
|
| 20. |
Guo Q,Li HY,Zhou YP,et al.CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.Eur J Clin Microbiol Infect Dis,2012,31(12):3281-3286.
|
| 21. |
陈银花,张启确,余木生,等.中国社区获得性肺炎病情评估标准与肺炎严重指数的效能比较.中华临床医师杂志(电子版),2012,6(18):148-150.
|
| 22. |
vander Eerden MM,Vlaspolder F,de Graaff CS,et al.Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia:a prospective randomised study.Thorax,2005,60(8):672-678.
|
| 23. |
Lujan M,Gallego M,Fontanals D,et al.Prospective observational study of bacteremic pneumococcal pneumonia:Effect of discordant therapy on mortality.Crit Care Med,2004,32(3):625-31.
|
| 24. |
Bruinsma N,Kristinsson KG,Bronzwaer S,et al.Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.J Antimicrob Chemother,2004,54(6):1045-1050.
|
| 25. |
File TM.Community-acquired pneumonia.Lancet,2003,362(9400):1991-2001.
|
| 26. |
刘又宁,陈民钧,赵铁梅,等.中国城市成人社区获得性肺炎665例病原学多中心调查.中华结核和呼吸杂志,2006,29(1):3-8.
|
| 27. |
Hu HC,Huang CC,Tsai YH,et al.Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified bacterial pathogens.Chang Gung Med J,2005,28(4):229-236.
|
| 28. |
Torres A,Serra-Batlles J,Ferrer A,et al.Severe community-acquired pneumonia.Epidemiology and prognostic factors.Am Rev Respir Dis,1991,144(2):312-318.
|
| 29. |
胡付品,朱德妹,汪复,等.2013年中国CHINET细菌耐药性监测.中国感染与化疗杂志,2014,14(5):365-374.
|
| 30. |
Cao B,Zhao CJ,Yin YD,et al.High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.Clin Infect Dis,2010,51(2):189-94.
|
